Business Of Biotech cover image

CAR T Therapy Cost Control With Laurence Cooper, M.D., Ph.D.

Business Of Biotech

00:00

How to Make a Genetically Modified T Cell

Ziafron: There are in general three major steps. The first is the genetic modification of the T cells. The second is the growth of those cells so that they achieve the expression of the introduced receptor, whether it's a car or a TCR. The third is the release criteria. Each one of those three things essentially has to be managed to make a clinical-grade product.

Play episode from 16:28
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app